Evidence map›Paper›PMID 29268759›Full record

Trial reportCritical care (London, England)2017

Comparison of the efficacy of three topical antiseptic solutions for the prevention of catheter colonization: a multicenter randomized controlled study.

Hideto Yasuda, Masamitsu Sanui, Takayuki Abe, Nobuaki Shime, Tetsuya Komuro, Junji Hatakeyama, Shohei Matsukubo, Shinji Kawano, Hiroshi Yamamoto, Kohkichi Andoh and 12 more

Open access · goldAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Critical care (London, England), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 3 pooled it
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 3 syntheses or guidelines pooled it, 39 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Skin antisepsis for reducing central venous catheter-related infections.The Cochrane database of systematic reviews · 2016
    Pooled it
  4. Article
  5. Review
  6. Article
  7. Article
  8. Observational
  9. Article
  10. Review
  11. Observational
  12. Indian Society of Critical Care Medicine Position Statement for Central Venous Catheterization and Management 2020.Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine · 2020
    Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 16 institutions in 1 country.

Hideto YasudaIntensive Care Unit, Department of Emergency and Critical Care Medicine, Japanese Red Cross Musashino Hospital, 1-26-1, Kyounanchou, Musashino-shi, Tokyo, 180-8610, Japan.
Masamitsu SanuiDepartment of Anesthesiology and Critical Care Medicine, Jichi Medical University Saitama Medical Center, 1-847, Amanuma-cho, Omiya-ku, Saitama-shi, Saitama, 330-8503, Japan. msanui@mac.com.ORCID 0000-0002-0184-0381
Takayuki AbeDepartment of Preventive Medicine and Public Health, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan.
Nobuaki ShimeDepartment of Emergency and Critical Care Medicine, Hiroshima University, Kasumi 1-2-3 Minami-ku, Hiroshima, 734-8551, Japan.
Tetsuya KomuroDepartment of Anesthesiology and Critical Care Medicine, Jichi Medical University Saitama Medical Center, 1-847, Amanuma-cho, Omiya-ku, Saitama-shi, Saitama, 330-8503, Japan.
Junji HatakeyamaDepartment of Intensive Care Medicine, Yokohama City Minato Red Cross Hospital, 3-12-1, Shin-yamashita, Naka-ku, Yokohama-Shi, Kanagawa, 231-8682, Japan.
Shohei MatsukuboDepartment of Emergency Medicine, Emergency and Critical Care Center, Kurashiki Central Hospital, 1-1-1 Miwa, Kurashiki, Okayama, 710-8602, Japan.
Shinji KawanoIntensive Care Unit, Department of Anesthesiology, Jikei University School of Medicine, 3-19-18, Nishishimbashi, Minato-ku, Tokyo, 105-8471, Japan.
Hiroshi YamamotoDepartment of Anesthesia, Toyonaka Municipal Hospital, 1-14-4, Shibaraha-chou, Toyonaka-shi, Osaka, 560-8565, Japan.
Kohkichi AndohEmergency and Critical Care Department, Division of Intensive Care, Sendai City Hospital, 1-1-1, Asutonaga-chou, Taihaku-ku, Sendai-shi, Miyagi, 982-8502, Japan.
Ryutaro SeoDepartment of Emergency Medicine, Kobe City Medical Center General Hospital, 2-2-1, Minatojima-minamimachi, Chuo-ku, Kobe-city, Hyogo, 650-0047, Japan.
Kyo InoueDepartment of Emergency and Critical Care Medicine, National Hospital Organization Kyoto Medical Center, 1-1 Mukaihata-cho, Fukakusa, Fushimi-ku, Kyoto-shi, Kyoto, 612-0861, Japan.
Eiichiro NodaDepartment of Emergency Medicine, Fukuoka City Hospital, 1-13, Yoshizuka-honmachi, Hakata-ku, Fukuoka-shi, Fukuoka, 812-0046, Japan.
Nobuyuki SaitoShock and Trauma Center, Chiba-Hokusoh Hospital, Nippon Medical School, 1715 Kamagari, Inzai, Chiba, 270-1694, Japan.
Satoshi NogamiDepartment of Anesthesiology, Okayama Medical Center, 1711-1, Taeki, Kita-ku, Okayama-shi, Okayama, 701-1192, Japan.
Kentaro OkamotoDepartment of Intensive Care Medicine, Tokyo Bay Urayasu Ichikawa Medical Center, 3-4-32, Toudaijima, Urayasu-shi, Chiba, 279-0001, Japan.
Ryota FukeDivision of Infectious Diseases and Infection Control, Tohoku Medical and Pharmaceutical University Hospital, 1-12-1, Fukumuro, Miyagino-ku, Sendai, 983-8512, Japan.
Yasuhiro GushimaDepartment of Acute Care and General Medicine, Saiseikai Kumamoto Hospital, 5-3-1, Chikami, Minami-ku, Kumamoto-shi, Kumamoto, 861-4193, Japan.
Atsuko KobayashiDepartment of Central Laboratory and Infection Control, Takarazuka City Hospital, 4-5-1, Kohama, Takarazuka-shi, Hyogo, 665-0827, Japan.
Toru TakebayashiDepartment of Preventive Medicine and Public Health, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan.
Alan Kawarai LeforDepartment of Surgery, Jichi Medical University, 3311-1, Yakushiji, Simono-shi, Tochigi, 329-0498, Japan.
for Japanese Society of Education for Physicians and Trainees in Intensive Care (JSEPTIC) Clinical Trial Group
Jichi Medical University · JPKeio University · JPChiba Hokusou Hospital · JPFukuoka City Hospital · JPHiroshima University · JPJikei University School of Medicine · JPKobe City Medical Center General Hospital · JPKurashiki Central Hospital · JPKyoto Medical Center · JPOkayama Medical Center · JPSaiseikai Kumamoto Hospital · JPSendai City Hospital · JPTakarazuka City Hospital · JPTohoku Medical and Pharmaceutical University Hospital · JPToyonaka Municipal Hospital · JPYokohama Municipal Minato Red Cross Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTo compare the efficacy of three antiseptic solutions [0.5%, and 1.0% alcohol/chlorhexidine gluconate (CHG), and 10% aqueous povidone-iodine (PVI)] for the prevention of intravascular catheter colonization, we conducted a randomized controlled trial in patients from 16 intensive care units in Japan.

methodsAdult patients undergoing central venous or arterial catheter insertions were randomized to have one of three antiseptic solutions applied during catheter insertion and dressing changes. The primary endpoint was the incidence of catheter colonization, and the secondary endpoint was the incidence of catheter-related bloodstream infections (CRBSI).

resultsOf 1132 catheters randomized, 796 (70%) were included in the full analysis set. Catheter-tip colonization incidence was 3.7, 3.9, and 10.5 events per 1000 catheter-days in 0.5% CHG, 1% CHG, and PVI groups, respectively (p = 0.03). Pairwise comparisons of catheter colonization between groups showed a significantly higher catheter colonization risk in the PVI group (0.5% CHG vs. PVI: hazard ratio, HR 0.33 [95% confidence interval, CI 0.12-0.95], p = 0.04; 1.0% CHG vs. PVI: HR 0.35 [95% CI 0.13-0.93], p = 0.04). Sensitivity analyses including all patients by multiple imputations showed consistent quantitative conclusions (0.5% CHG vs. PVI: HR 0.34, p = 0.03; 1.0% CHG vs. PVI: HR 0.35, p = 0.04). No significant differences were observed in the incidence of CRBSI between groups.

conclusionsBoth 0.5% and 1.0% alcohol CHG are superior to 10% aqueous PVI for the prevention of intravascular catheter colonization.

trial registrationJapanese Primary Registries Network; No.: UMIN000008725 Registered on 1 September 2012.

Indexed as

Administration, TopicalAgedAged, 80 and overAnti-Infective Agents, LocalCatheterization, Central VenousCatheter-Related InfectionsChlorhexidineFemaleHumansIncidenceIntensive Care UnitsJapanMaleMiddle AgedPovidone-IodineUrinary CatheterizationAnti-Infective Agents, LocalChlorhexidinechlorhexidine gluconatePovidone-IodineAnti-bacterial agentsAnti-infective agentsCatheter-related infectionsCathetersChlorhexidineLocalPovidone-iodine

Identifiers

PMID29268759
PMCPMC5740719
OpenAlexW2776603969

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.